Did you have a pre-eclamptic pregnancy and received low dose aspirin in subsequent pregnancies?
Researchers at the Rockefeller University are seeking to evaluate the genetic, laboratory and clinical factors associated with aspirin responsiveness in the prevention of pre-eclampsia.
You may be eligible if you:
· Are a woman aged 18-45 years with prior history of preeclampsia who received low dose (81mg) aspirin in a subsequent gestation
· Had a subsequent pregnancy that lasted beyond 20 weeks of gestation
· Are willing to abstain from medications known to interfere with platelet function for one week prior to blood draw
Participation includes:
1 screening telephone call
1-visit to the RU Hospital to give a saliva sample
2nd visit to the RU Hospital for 2 small blood draws, 1 each before and after being administered low dose aspirin